___

• Sayhan M B, Sezenler E, Nalbur I H, Yağcı G, Gezer E. Herpes Zoster Oftalmikus JAEMCR 2012; 3: 74-6. [CrossRef]
• Catron T, Hern HG. Herpes Zoster Ophthalmicus. West J Emerg Med 2008; 9: 174-6.
• Heymann AD, Chodick G, Karpati T, Kamer L, Kremer E, Green M.S, et al. Diabetes as a risk factor for herpes zoster infection: results of a population-based study in Israel. Infection 2008; 36: 226-30. [CrossRef]
• Gross G, Schöfer H, Wassilew S, Friese K, Timm A, Guthoff R, et al. Herpes zoster guideline of the German Dermatology Society (DDG). J Clin Virol 2003; 26: 277-89; discussion 291-3. [CrossRef]
• Schmader K, Gnann J.W. Watson C.P. The epidemiological, clinical, and pathological rationale for the herpes zoster vaccine. J Infect Dis 2008;197: 207-15. [CrossRef]
• Galluzzi KE. Managing herpes zoster and postherpetic neuralgia. J Am Osteopath Assoc 2009; 109: 7-12.